191 related articles for article (PubMed ID: 27042274)
1. Phenotyping of type 2 diabetes mellitus at onset on the basis of fasting incretin tone: Results of a two-step cluster analysis.
Amato MC; Pizzolanti G; Torregrossa V; Pantò F; Giordano C
J Diabetes Investig; 2016 Mar; 7(2):219-25. PubMed ID: 27042274
[TBL] [Abstract][Full Text] [Related]
2. Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response.
Tura A; Bagger JI; Ferrannini E; Holst JJ; Knop FK; Vilsbøll T; Mari A
Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1123-1129. PubMed ID: 29162361
[TBL] [Abstract][Full Text] [Related]
3. Incretins in fibrocalculous pancreatic diabetes: A unique subtype of pancreatogenic diabetes.
Ghosh I; Mukhopadhyay P; Das K; Anne M B; Ali Mondal S; Basu M; Nargis T; Pandit K; Chakrabarti P; Ghosh S
J Diabetes; 2021 Jun; 13(6):506-511. PubMed ID: 33247879
[TBL] [Abstract][Full Text] [Related]
4. Preserved GLP-1 and exaggerated GIP secretion in type 2 diabetes and relationships with triglycerides and ALT.
Alssema M; Rijkelijkhuizen JM; Holst JJ; Teerlink T; Scheffer PG; Eekhoff EM; Gastaldelli A; Mari A; Hart LM; Nijpels G; Dekker JM
Eur J Endocrinol; 2013 Oct; 169(4):421-30. PubMed ID: 23864340
[TBL] [Abstract][Full Text] [Related]
5. Common variants in the hERG (KCNH2) voltage-gated potassium channel are associated with altered fasting and glucose-stimulated plasma incretin and glucagon responses.
Engelbrechtsen L; Mahendran Y; Jonsson A; Gjesing AP; Weeke PE; Jørgensen ME; Færch K; Witte DR; Holst JJ; Jørgensen T; Grarup N; Pedersen O; Vestergaard H; Torekov S; Kanters JK; Hansen T
BMC Genet; 2018 Mar; 19(1):15. PubMed ID: 29548277
[TBL] [Abstract][Full Text] [Related]
6. Postprandial incretin and islet hormone responses and dipeptidyl-peptidase 4 enzymatic activity in patients with maturity onset diabetes of the young.
Østoft SH; Bagger JI; Hansen T; Hartmann B; Pedersen O; Holst JJ; Knop FK; Vilsbøll T
Eur J Endocrinol; 2015 Aug; 173(2):205-15. PubMed ID: 25953829
[TBL] [Abstract][Full Text] [Related]
7. Assessment of incretins in oral glucose and lipid tolerance tests may be indicative in the diagnosis of metabolic syndrome aggravation.
Kiec-Klimczak M; Malczewska-Malec M; Razny U; Zdzienicka A; Gruca A; Goralska J; Pach D; Gilis-Januszewska A; Dembinska-Kiec A; Hubalewska-Dydejczyk A
J Physiol Pharmacol; 2016 Apr; 67(2):217-26. PubMed ID: 27226181
[TBL] [Abstract][Full Text] [Related]
8. Postprandial responses of incretin and pancreatic hormones in non-diabetic patients with end-stage renal disease.
Idorn T; Knop FK; Jørgensen M; Holst JJ; Hornum M; Feldt-Rasmussen B
Nephrol Dial Transplant; 2014 Jan; 29(1):119-27. PubMed ID: 24078334
[TBL] [Abstract][Full Text] [Related]
9. Effects of short-term therapy with glibenclamide and repaglinide on incretin hormones and oxidative damage associated with postprandial hyperglycaemia in people with type 2 diabetes mellitus.
Stephens JW; Bodvarsdottir TB; Wareham K; Prior SL; Bracken RM; Lowe GD; Rumley A; Dunseath G; Luzio S; Deacon CF; Holst JJ; Bain SC
Diabetes Res Clin Pract; 2011 Nov; 94(2):199-206. PubMed ID: 21835486
[TBL] [Abstract][Full Text] [Related]
10. The effect of meal frequency in a reduced-energy regimen on the gastrointestinal and appetite hormones in patients with type 2 diabetes: A randomised crossover study.
Belinova L; Kahleova H; Malinska H; Topolcan O; Windrichova J; Oliyarnyk O; Kazdova L; Hill M; Pelikanova T
PLoS One; 2017; 12(4):e0174820. PubMed ID: 28369078
[TBL] [Abstract][Full Text] [Related]
11. Increased postprandial GIP and glucagon responses, but unaltered GLP-1 response after intervention with steroid hormone, relative physical inactivity, and high-calorie diet in healthy subjects.
Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
J Clin Endocrinol Metab; 2011 Feb; 96(2):447-53. PubMed ID: 21047927
[TBL] [Abstract][Full Text] [Related]
12. Effects of variations in duodenal glucose load on glycaemic, insulin, and incretin responses in type 2 diabetes.
Ma J; Pilichiewicz AN; Feinle-Bisset C; Wishart JM; Jones KL; Horowitz M; Rayner CK
Diabet Med; 2012 May; 29(5):604-8. PubMed ID: 22004512
[TBL] [Abstract][Full Text] [Related]
13. Plasma Incretin Levels and Dipeptidyl Peptidase-4 Activity in Patients with Obstructive Sleep Apnea.
Matsumoto T; Harada N; Azuma M; Chihara Y; Murase K; Tachikawa R; Minami T; Hamada S; Tanizawa K; Inouchi M; Oga T; Mishima M; Chin K
Ann Am Thorac Soc; 2016 Aug; 13(8):1378-87. PubMed ID: 27104640
[TBL] [Abstract][Full Text] [Related]
14. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ
J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
[TBL] [Abstract][Full Text] [Related]
15. Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects.
Knop FK; Konings E; Timmers S; Schrauwen P; Holst JJ; Blaak EE
Diabet Med; 2013 Oct; 30(10):1214-8. PubMed ID: 23663119
[TBL] [Abstract][Full Text] [Related]
16. Palaeolithic diet decreases fasting plasma leptin concentrations more than a diabetes diet in patients with type 2 diabetes: a randomised cross-over trial.
Fontes-Villalba M; Lindeberg S; Granfeldt Y; Knop FK; Memon AA; Carrera-Bastos P; Picazo Ó; Chanrai M; Sunquist J; Sundquist K; Jönsson T
Cardiovasc Diabetol; 2016 May; 15():80. PubMed ID: 27216013
[TBL] [Abstract][Full Text] [Related]
17. The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects.
Elahi D; McAloon-Dyke M; Fukagawa NK; Meneilly GS; Sclater AL; Minaker KL; Habener JF; Andersen DK
Regul Pept; 1994 Apr; 51(1):63-74. PubMed ID: 8036284
[TBL] [Abstract][Full Text] [Related]
18. Serum Levels of Incretin Hormones - GLP-1 and GIP in Patients with Type 1 Diabetes Mellitus.
Stanchev PE; Orbetzova MM; Terzieva DD; Davcheva D; Iliev DA; Petrov SV; Koleva DI; Nonchev BI
Folia Med (Plovdiv); 2019 Mar; 61(1):76-83. PubMed ID: 31237842
[TBL] [Abstract][Full Text] [Related]
19. Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects.
Vilsbøll T; Krarup T; Madsbad S; Holst JJ
Regul Pept; 2003 Jul; 114(2-3):115-21. PubMed ID: 12832099
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of delayed-release hydrolyzed pine nut oil on glucose tolerance, incretins, ghrelin and appetite in healthy humans.
Sørensen KV; Korfitzen SS; Kaspersen MH; Ulven ER; Ekberg JH; Bauer-Brandl A; Ulven T; Højlund K
Clin Nutr; 2021 Apr; 40(4):2169-2179. PubMed ID: 33059911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
